Noticias de CSTL_US

Noticias del mercado

Últimas noticias sobre CSTL_US — 155 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CSTL_US ✕ 155 resultados
21/04/2026 CSTL_US — Yahoo Finance ES ← EN
Castle Biosciences presentará nuevos datos que demuestran la capacidad de DecisionDx®-Melanoma para identificar pacientes con mayor riesgo de recurrencia y malos resultados dentro del melanoma en etapa temprana en EADO y ACMS

Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS

21/04/2026 CSTL_US — Yahoo Finance
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
21/04/2026 CSTL_US — Investing.com
Castle Biosciences to present melanoma test data at conferences
21/04/2026 CSTL_US — Stock Titan
New data suggest some early melanomas carry higher relapse risk
21/04/2026 CSTL_US — StreetInsider
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
21/04/2026 CSTL_US — PR Newswire
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS
21/04/2026 CSTL_US — Investing.com UK
Castle Biosciences to present melanoma test data at conferences By Investing.com
20/04/2026 CSTL_US — GuruFocus ES ← EN
CSTL mantenido por Canaccord Genuity - Precio objetivo reducido a $40

CSTL Maintained by Canaccord Genuity -- Price Target Lowered to $40

20/04/2026 CSTL_US — Stock Traders Daily
(CSTL) as a Liquidity Pulse for Institutional Tactics
17/04/2026 CSTL_US — DirectorsTalk Interviews
Castle Biosciences, Inc. (CSTL) Stock Analysis: A 97% Upside Potential Beckons Investors
17/04/2026 CSTL_US — MarketBeat
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Recommendation of "Moderate Buy" by Analysts
15/04/2026 CSTL_US — Barchart
Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026
15/04/2026 CSTL_US — Newser
CSTL (Castle Biosciences Inc.) reports narrower than expected Q4 2025 loss and slight revenue growth, lifting shares modestly. - AI Stock Signals
15/04/2026 CSTL_US — BioSpace
Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026
15/04/2026 CSTL_US — Stock Titan
After the close on May 6, Castle Biosciences will break down Q1
15/04/2026 CSTL_US — Newser
CSTL (Castle Biosciences Inc.) reports narrower than expected Q4 2025 loss and slight revenue growth, lifting shares modestly. - Earnings Beat
15/04/2026 CSTL_US — Yahoo Finance
Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026
15/04/2026 CSTL_US — Financial Times
Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026
15/04/2026 CSTL_US — Newser
CSTL (Castle Biosciences Inc.) reports narrower than expected Q4 2025 loss and slight revenue growth, lifting shares modestly. - Recovery Stocks
10/04/2026 CSTL_US — Financial Times
Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year

Página 5 de 8

keyboard_arrow_up